AzTrials
AzTrials

CaregiversNCT05028452

Feasibility of Internet Based Support (Carer eSupport) for Informal Caregivers of Patients With Head and Neck Cancer

A study testing Internet based support in people with Caregivers and Head and Neck Cancer, run by Uppsala University at 4 sites in Sweden.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Informal caregivers to patients with head and neck cancer report that they are unprepared for caregiving, that they experience a high caregiver burden and a deteriorated health. The aim is to develop an internet based intervention for informal caregivers of individuals with head and neck cancer and evaluate the… Read more about this study

Who is it for?
Ages 18 years and older
What is being tested?
Internet based support
Could I receive a placebo?
No, everyone receives an active treatment
How many people
32 participants
Where
4 sitesSweden
Study dates
17 Apr 2023to 30 Sep 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Informal caregivers (defined by the patients) to patients with head and neck cancer who are about to start treatment, undergoing treatment or have completed treatment within the past month.

Who cannot join

  • Confusion or dementia, inability to understand, speak or read Swedish.

Trial locations and contacts

4 sites in 1 country.

Sweden4 sites
  • Sahlgrenska university hospital

    Gothenburg, Västra Götaland County, 41345

  • Örebro University Hospital

    Örebro, Blekinge Län, 70185

  • Norrland University Hospital

    Umeå, Västerbotten County, 90737

  • Uppsala university hospital

    Uppsala, Uppsala County, 75105

Other trials in Sweden

About this study

Official title: Carer eSupport: Rationale and Design of an Internet-based Support for Informal Caregivers of Individuals With Head and Neck Cancer

Informal caregivers to patients with head and neck cancer report that they are unprepared for caregiving, that they experience a high caregiver burden and a deteriorated health. The aim is to develop an internet based intervention for informal caregivers of individuals with head and neck cancer and evaluate the feasibility and acceptability of the intervention. The internet based intervention (Carer eSupport) will be based on scientific evidence, established theoretical frameworks and focus groups with caregivers and health care professionals. The feasibility and acceptability of Carer eSupport will be evaluated by 30 caregivers who will have access to Carer eSupport during one months. The feasibility and acceptability of Carer eSupport will be evaluated with quantitative and qualitative data.

Being tested
Internet based support
Medical subject headings
Head and Neck Neoplasms

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Internet based supportOther

    Also called Carer eSupport

    Carer eSupport is designed to prepare informal caregivers for caregiving, to decrease caregiver burden and prevent a deteriorated health.

Study groups in NCT05028452
Study groupRoleWhat they receive
Internet based supportOtherInternet based support for informal caregivers to individuals who are undergoing treatment for head and neck cancer.
Receives: Other: Internet based support

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Inclusion rate

    The proportion of caregivers who give informed consent for participation

    Measured: 4 months

  2. Utilization of Carer eSupport

    The proportion of included caregivers who take use of Carer eSupport

    Measured: 2 months

  3. Attrition

    The proportion of included caregivers who withdraw from the study

    Measured: 3 months

  4. Completion of questionnaires

    The proportion of included caregivers who complete questionnaires

    Measured: 3 months

  5. Perceived feasibility

    Qualitative data from semi-structured individual interviews exploring perceived feasibility of Carer eSupport.

    Measured: Within 1 months after completion of testing Carer eSupport.

  6. Perceived acceptability

    Qualitative data from semi-structured individual interviews exploring perceived acceptability of Carer eSupport.

    Measured: Within 1 months after completion of testing Carer eSupport.

Secondary outcomes (5)
  1. The Preparedness for caregiving scale

    A brief 8-item self-report measure assessing preparedness for caregiving, a potential primary outcome in a future randomized controlled trial.

    Measured: Assessed at baseline and at 1 months after access to Carer eSupport

  2. Caregiver´s burden scale

    A 22-item self-report measure assessing caregiver burden, a potential primary outcome in a future randomized controlled trial.

    Measured: Assessed at baseline and at 1 months after access to Carer eSupport.

  3. Short Form Health Survey (SF-36), v2.

    A 36-item self-report measure assessing self-perceived health, a potential secondary outcome in a future randomized controlled trial.

    Measured: Assessed at baseline and at 1 months after access to Carer eSupport.

  4. The Depression Anxiety Stress Scale-21

    A 21-item self-report measure assessing depression, anxiety, and stress, a potential secondary outcome in a future randomized controlled trial.

    Measured: Assessed at baseline and at 1 months after access to Carer eSupport.

  5. The Multidimensional fatigue inventory

    A 20-item self-report measure assessing five dimensions of fatigue, a potential secondary outcome in a future randomized controlled trial.

    Measured: Assessed at baseline and at 1 months after access to Carer eSupport.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted31 Aug 2021
  2. Study start17 Apr 2023
  3. Primary completion30 Sep 2023
  4. Study completion30 Sep 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Model description
Single group posttest only design
Masking
None (open label)
Enrolment
32 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05028452
Sponsor's protocol ID
Carer eSupport
Status last verified
Feb 2024
First submitted
24 Aug 2021
Last updated
16 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No: There is no plan to make individual participant data (IPD) available to other researchers, since this is a feasibility study.

Publications

  • Ahmad A, Cajander A, Langegard U, Johansson B, Henriksson A, Pettersson M, Ahmad W, Tiblom Ehrsson Y. The Development of a Web-Based Application to Support Informal Caregivers of Individuals With Head and Neck Cancer: Human-Centered Design Approach. JMIR Hum Factors. 2026 Apr 8;13:e81896. doi: 10.2196/81896.

    PubMed 41950374
  • Langegard U, Cajander A, Carlsson M, von Essen L, Ahmad A, Laurell G, Tiblom Ehrsson Y, Johansson B. Internet-based support for informal caregivers to individuals with head and neck cancer (Carer eSupport): a study protocol for the development and feasibility testing of a complex online intervention. BMJ Open. 2022 May 27;12(5):e057442. doi: 10.1136/bmjopen-2021-057442.

    PubMed 35623759

Questions about this trial

What is this clinical trial studying?

A study testing Internet based support in people with Caregivers and Head and Neck Cancer, run by Uppsala University at 4 sites in Sweden.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 4 sites in Sweden. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Inclusion rate (time frame: 4 months). The study lists 6 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05028452, which also lists 2 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in